CRT Capital to host a conference 1:1 Investor Conference is being held in Greenwich, CT on September 23. Forest Labs announces FDA designates ceftazidime/avibactam as QIDP Forest Laboratories announced that the U.S. FDA has designated its investigational drug, ceftazidime/avibactam, a qualified infectious disease product.
http://www.theflyonthewall.com/permalinks/entry.php/FRXid1891441/FRX-Forest-Labs-files-patent-infringement-suits-against-several-companies-
http://www.theflyonthewall.com/permalinks/entry.php/FRXid1891441/FRX-Forest-Labs-files-patent-infringement-suits-against-several-companies-
No comments:
Post a Comment